Trials / Recruiting
RecruitingNCT05956158
RISE: A Remote Study of Insomnia Treatment in Crohn's Disease
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 83 (estimated)
- Sponsor
- Dartmouth-Hitchcock Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess whether the investigators can treat insomnia in people with Crohn's disease, and if insomnia treatment can make other things better, like pain or inflammation.
Detailed description
People with Crohn's disease often suffer from sleep problems. Long term, sleep problems may lead to more flares of Crohn's disease or other complications. In general, patients with Crohn's disease also report that sleep problems can worsen symptoms of Crohn's disease the next day. In people with other medical problems, research has also shown that having sleep problems can make other things worse, such as pain and inflammation. In this study, the investigators want to understand if they can treat sleep problems in people with Crohn's disease, and what else might improve if sleep gets better. If this study is successful, it will help the investigators understand more about how to treat insomnia in people with Crohn's disease and how sleep impacts pain and inflammation. Long term, this information will be helpful in understanding how best to take care of people with Crohn's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Behavioral Treatment | This treatment is designed to help participants make changes to behavior patterns and thoughts that contribute to insomnia. |
| BEHAVIORAL | Sleep Education Treatment | This treatment is designed to help participants understand the relationships among sleep, pain, and Crohn's disease and to make changes to insomnia-related behaviors. |
Timeline
- Start date
- 2023-11-28
- Primary completion
- 2026-04-30
- Completion
- 2026-11-30
- First posted
- 2023-07-21
- Last updated
- 2025-10-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05956158. Inclusion in this directory is not an endorsement.